ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells

Abstract

Our study reveals an interesting post-translational mechanism between ER alpha and ZNF213 in breast cancer. Targeting ZNF213 could be an appealing strategy for ER alpha positive breast cancer.